Bio-Techne Corp. buy Citigroup Inc.
Start price
21.08.25
/
50%
€46.80
Target price
21.08.26
€60.09
Performance (%)
33.97%
Price
30.07.26
€62.46
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ for Bio-Techne Corp. has seen massive gains of 33.97%. A total of €0.24 was paid as dividends for this prediction. This prediction currently runs until 21.08.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bio-Techne Corp. | -0.983% | -0.983% |
| iShares Core DAX® | 2.591% | 2.691% |
| iShares Nasdaq 100 | -0.915% | -7.368% |
| iShares Nikkei 225® | 0.145% | -10.196% |
| iShares S&P 500 | -0.367% | -0.833% |
Comments by Citigroup_Inc_ for this prediction
In the thread Bio-Techne Corp. diskutieren
Bio-Techne (NASDAQ:TECH) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $70.00 price target on the stock, up previously from $55.00.
Ratings data for TECH provided by MarketBeat